Deal announcement

Krzewinski+Partners is very proud to have assisted Nomainvest with its investment in OneLife, a spin-out of Realco designing, developing & producing enzymatic solutions that contribute to the prevention of Antimicrobial Resistance (AMR) and Healthcare Acquired Infections (HAI). The funding round amounting to 3.8M EUR was mainly subscribed by Nomainvest, Wallonie Entreprendre and Noshaq.

OneLife is a Belgian player in the medical hygiene and antimicrobial resistance market, specializing in cleaning and infection control solutions for medical environments. Present in 25 countries, OneLife markets innovative enzymatic detergents for deep cleaning of endoscopes, surgical instruments, dental equipment and medical devices; solutions ranging from detection to treatment and prevention of biofilms and bioburden.

As a family-owned holding company, Nomainvest acts as a shareholder and strategic partner for ambitious companies driven by competent, motivated teams with innovative projects. It supports these companies, helping them to break new growth ground. In this way, Nomainvest plays an active role in the economic development of the regions in which it invests, and contributes to the creation of sustainable jobs.

Deal team: Christophe Krzewinski - Samuel Darcheville